Autor: "Kakizoe, Tadao" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Impact of coronavirus disease 2019 on the number of newly diagnosed cancer patients and examinations and surgeries performed for cancer in Japan: a nationwide study.
Autorzy:: Terashima T; Department of Respiratory Medicine, Tokyo Dental College, Ichikawa General Hospital, 5-11-13 Sugano, Ichikawa, Chiba, 272-0824, Japan. .
Konishi H; Japan Cancer Society, Tokyo, Japan.
Sato Y; Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.
Igarashi M; Department of Gastroenterology, Tokai University School of Medicine, Tokyo Hospital, Tokyo, Japan.
Yanagibashi T; Department of Gastroenterology, Kanagawa Prefectural Ashigarakami Hospital, Kanagawa, Japan.
Konno R; Department of Obstetrics and Gynecology, Jichi Medical University, Saitama Medical Center, Saitama, Japan.
Saya H; Division of Gene Regulation, Institute for Advanced Medical Research, Graduate School of Medicine, Keio University, Tokyo, Japan.
Doki Y; Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Kakizoe T; Japan Cancer Society, Tokyo, Japan.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2022 Dec 13; Vol. 22 (1), pp. 1303. Date of Electronic Publication: 2022 Dec 13.
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19*/epidemiology
Uterine Cervical Neoplasms*
Stomach Neoplasms*/diagnosis
Breast Neoplasms*/diagnosis
Colorectal Neoplasms*
Female ; Humans ; Pandemics ; Retrospective Studies ; Japan/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Patient-reported outcomes following neoadjuvant endocrine therapy, external beam radiation, and adjuvant continuous/intermittent endocrine therapy for locally advanced prostate cancer: A randomized phase III trial.
Autorzy:: Yokomizo A; Department of Urology, Graduate School of Medicine, Kyusyu University, Fukuoka, Japan.; Department of Urology, Harasanshin Hospital, Fukuoka, Japan.
Koga H; Department of Urology, Graduate School of Medicine, Kyusyu University, Fukuoka, Japan.; Department of Urology, Harasanshin Hospital, Fukuoka, Japan.
Ito K; Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Takezawa Y; Department of Urology, Isesaki Municipal Hospital, Isesaki, Japan.
Komiyama M; Department of Urology, National Cancer Center Hospital, Tokyo, Japan.
Nishimura K; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
Yonese J; Department of Urology, Cancer Institute Hospital, Tokyo, Japan.
Hashine K; Department of Urology, Shikoku Cancer Center, Matsuyama, Japan.
Masumori N; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Arai G; Department of Urology, Dokkyo University Koshigaya Hospital, Koshigaya, Japan.
Saito S; Department of Urology, Tokyo Medical Center, Tokyo, Japan.
Shinohara M; Department of Urology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
Shimizu N; Department of Urology, Gunma Cancer Center Hospital, Ohta, Japan.
Yamauchi A; Department of Urology, Ibaraki Prefectural Central Hospital, Kasama, Japan.
Satoh T; Department of Urology, Kitasato University School of Medicine, Sagamihara, Japan.
Tochigi T; Department of Urology, Miyagi Cancer Center, Natori, Japan.
Kobayashi M; Department of Urology, Isesaki Municipal Hospital, Isesaki, Japan.
Fujimoto H; Department of Urology, National Cancer Center Hospital, Tokyo, Japan.
Kakimoto KI; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.
Fukui I; Department of Urology, Cancer Institute Hospital, Tokyo, Japan.
Tsukamoto T; Sapporo Medical University School of Medicine, Sapporo, Japan.
Nozaki M; Department of Radiation Oncology, Dokkyo University Koshigaya Hospital, Koshigaya, Japan.
Karasawa K; Department of Radiation Oncology, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan.
Hasumi M; Department of Urology, Gunma Cancer Center Hospital, Ohta, Japan.
Ohtani M; Department of Urology, Ibaraki Prefectural Central Hospital, Kasama, Japan.
Ishiyama H; Department of Radiation and Radiation Oncology, Kitasato University, Sagamihara, Japan.
Kuwahara M; Sendai Jin-hinyokika, Sendai, Japan.
Harada M; Kanagawa Cancer Center, Yokohama, Japan.
Ohashi Y; University of Tokyo, Tokyo, Japan.
Kotake T; Kotake Clinic, Osaka, Japan.
Kakizoe T; President, Japan Cancer Society, Tokyo, Japan.
Suzuki K; Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan.
Naito S; Department of Urology, Graduate School of Medicine, Kyusyu University, Fukuoka, Japan.
Yamanaka H; Institute for Preventive Medicine, Kurosawa Hospital, Takasaki, Japan.; Pokaż więcej
Corporate Authors:: National Research Project on Endocrine-Radiation Combination Therapy for Locally Advanced Prostate Cancer investigators
Źródło:: Cancer medicine [Cancer Med] 2021 May; Vol. 10 (10), pp. 3240-3248. Date of Electronic Publication: 2021 May 01.
Typ publikacji:: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Androgen Antagonists/*therapeutic use
Prostatic Neoplasms/*drug therapy
Prostatic Neoplasms/*radiotherapy
Aged, 80 and over ; Combined Modality Therapy/methods ; Humans ; Male ; Neoadjuvant Therapy/methods ; Patient Reported Outcome Measures

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Effectiveness of HPV vaccination against the development of high-grade cervical lesions in young Japanese women.
Autorzy:: Shiko Y; Biostatistics Section, Clinical Research Center, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8677, Japan.
Konno R; Department of Obstetrics and Gynecology, Jichi Medical University Saitama Medical Center, Omiya-ku, Saitama, 330-8530, Japan. .
Konishi H; Japan Cancer Society, Tokyo, Japan.
Sauvaget C; Screening Group, Early Detection and Prevention Section, International Agency for Research on Cancer (WHO), Lyon, France.
Ohashi Y; Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan.
Kakizoe T; Japan Cancer Society, Tokyo, Japan.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2020 Nov 05; Vol. 20 (1), pp. 808. Date of Electronic Publication: 2020 Nov 05.
Typ publikacji:: Journal Article
MeSH Terms:: Vaccination*
Papillomaviridae/*immunology
Papillomavirus Infections/*prevention & control
Papillomavirus Vaccines/*immunology
Uterine Cervical Neoplasms/*prevention & control
Uterine Cervical Dysplasia/*prevention & control
Adult ; Cross-Sectional Studies ; Female ; Humans ; Immunization Programs ; Incidence ; Japan/epidemiology ; Papillomavirus Infections/epidemiology ; Papillomavirus Vaccines/administration & dosage ; Prevalence ; Treatment Outcome ; Uterine Cervical Neoplasms/classification ; Uterine Cervical Neoplasms/virology ; Young Adult ; Uterine Cervical Dysplasia/classification ; Uterine Cervical Dysplasia/virology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Genomic Landscape of Experimental Bladder Cancer in Rodents and Its Application to Human Bladder Cancer: Gene Amplification and Potential Overexpression of Cyp2a5/CYP2A6 Are Associated with the Invasive Phenotype.
Autorzy:: Kanemoto K; Division of Cancer Development System, National Cancer Center Research Institute, Tokyo, Japan.; Department of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Fukuta K; Department of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Kawai N; Department of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Tozawa K; Department of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Ochiai M; Division of Cancer Development System, National Cancer Center Research Institute, Tokyo, Japan.
Okamoto K; Division of Cancer Differentiation, National Cancer Center Research Institute, Tokyo, Japan.
Ohnami S; Division of Genetics, National Cancer Center Research Institute, Tokyo, Japan.
Sakamoto H; Division of Genetics, National Cancer Center Research Institute, Tokyo, Japan.
Yoshida T; Division of Genetics, National Cancer Center Research Institute, Tokyo, Japan.
Kanai Y; Division of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan.
Katoh M; Department of Omics Network, National Cancer Center Research Institute, Tokyo, Japan.
Yasui T; Department of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Kohri K; Department of Nephro-Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Kakizoe T; National Cancer Center Research Institute, Tokyo, Japan.
Nakagama H; Division of Cancer Development System, National Cancer Center Research Institute, Tokyo, Japan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2016 Nov 30; Vol. 11 (11), pp. e0167374. Date of Electronic Publication: 2016 Nov 30 (Print Publication: 2016).
Typ publikacji:: Journal Article
MeSH Terms:: Gene Amplification*
Gene Expression Regulation, Neoplastic*
Genomics*
Phenotype*
Aryl Hydrocarbon Hydroxylases/*genetics
Cytochrome P-450 CYP2A6/*genetics
Cytochrome P450 Family 2/*genetics
Urinary Bladder Neoplasms/*pathology
Animals ; Cell Line, Tumor ; Gene Dosage ; Humans ; Male ; Mice ; Neoplasm Invasiveness ; Rats ; Synteny ; Urinary Bladder Neoplasms/enzymology ; Urinary Bladder Neoplasms/genetics